Durham, NC, United States of America

Herbert I Hurwitz

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 2.1

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Hillsborough, NC (US) (2015 - 2017)
  • Durham, NC (US) (2016 - 2022)

Company Filing History:


Years Active: 2015-2022

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Herbert I Hurwitz: Innovator in Cancer Treatment

Introduction

Herbert I Hurwitz is a prominent inventor based in Durham, NC (US), known for his significant contributions to cancer treatment methodologies. With a total of 8 patents, Hurwitz has focused on developing innovative methods to predict and enhance the effectiveness of cancer therapies.

Latest Patents

Hurwitz's latest patents include groundbreaking methods for predicting the responsiveness of cancer to VEGF targeting agents. These methods involve obtaining a sample from a subject and determining the expression levels of biomarkers such as VEGF-D and PlGF. By comparing these levels to reference standards, the methods aim to predict how well a cancer will respond to treatment. Additionally, he has developed methods for prognosing and treating pancreatic cancer, which include assessing biomarkers like ANG-2, SDF-1, and IGFBP-1 to tailor treatment plans effectively.

Career Highlights

Hurwitz is affiliated with Duke University, where he has been instrumental in advancing cancer research. His work has not only contributed to the scientific community but has also provided hope for patients undergoing cancer treatment. His innovative approaches have the potential to significantly improve treatment outcomes.

Collaborations

Some of his notable coworkers include Andrew B Nixon and Mark D Starr, who have collaborated with him on various research projects aimed at enhancing cancer therapies.

Conclusion

Herbert I Hurwitz stands out as a key figure in the field of cancer treatment innovation. His patents and research efforts continue to pave the way for more effective cancer therapies, ultimately benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…